Financial Services
Compare Stocks
4 / 10Stock Comparison
VACHU vs EVR vs LAZ vs HLI
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
VACHU vs EVR vs LAZ vs HLI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Financial Services | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $551M | $13.43B | $4.35B | $9.72B |
| Revenue (TTM) | $0.00 | $3.88B | $3.19B | $2.39B |
| Net Income (TTM) | $7M | $592M | $237M | $448M |
| Gross Margin | — | 99.4% | 31.8% | 38.5% |
| Operating Margin | — | 20.5% | 13.0% | 21.0% |
| Forward P/E | 46.7x | 17.7x | 16.6x | 18.1x |
| Total Debt | $0.00 | $1.16B | $2.58B | $438M |
| Cash & Equiv. | $182K | $1.47B | $1.50B | $971M |
VACHU vs EVR vs LAZ vs HLI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | Jun 26 | Return |
|---|---|---|---|
| Voyager Acquisition… (VACHU) | 100 | 168.3 | +68.3% |
| Evercore Inc. (EVR) | 100 | 138.0 | +38.0% |
| Lazard Ltd (LAZ) | 100 | 92.5 | -7.5% |
| Houlihan Lokey, Inc. (HLI) | 100 | 88.9 | -11.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VACHU vs EVR vs LAZ vs HLI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VACHU is the #2 pick in this set and the best alternative if growth and momentum is your priority.
- 130.0% NII/revenue growth vs LAZ's 3.2%
- +61.7% vs HLI's -19.0%
EVR is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 29.5%, EPS growth 54.7%
- 6.0% 10Y total return vs HLI's 5.4%
LAZ is the clearest fit if your priority is defensive.
- Beta 1.73, yield 3.8%, current ratio 29.35x
- Lower P/E (16.6x vs 17.7x)
- 3.8% yield, vs EVR's 1.0%, (1 stock pays no dividend)
HLI carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 11 yrs, beta 0.85, yield 1.7%
- Lower volatility, beta 0.85, Low D/E 20.1%, current ratio 1.38x
- PEG 1.15 vs EVR's 1.56
- Efficiency ratio 0.2% vs EVR's 0.8% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 130.0% NII/revenue growth vs LAZ's 3.2% | |
| Value | Lower P/E (16.6x vs 17.7x) | |
| Quality / Margins | Efficiency ratio 0.2% vs EVR's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.85 vs EVR's 1.81, lower leverage | |
| Dividends | 3.8% yield, vs EVR's 1.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +61.7% vs HLI's -19.0% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs EVR's 0.8% |
VACHU vs EVR vs LAZ vs HLI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VACHU vs EVR vs LAZ vs HLI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HLI leads in 1 of 6 categories
LAZ leads 1 • EVR leads 1 • VACHU leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HLI leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
EVR and VACHU operate at a comparable scale, with $3.9B and $0 in trailing revenue. HLI is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to LAZ's 7.4%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $3.9B | $3.2B | $2.4B |
| EBITDAEarnings before interest/tax | -$4M | $804M | $384M | $609M |
| Net IncomeAfter-tax profit | $7M | $592M | $237M | $448M |
| Free Cash FlowCash after capex | -$412,702 | $1.2B | $519M | $739M |
| Gross MarginGross profit ÷ Revenue | — | +99.4% | +31.8% | +38.5% |
| Operating MarginEBIT ÷ Revenue | — | +20.5% | +13.0% | +21.0% |
| Net MarginNet income ÷ Revenue | — | +15.3% | +7.4% | +16.7% |
| FCF MarginFCF ÷ Revenue | — | +30.5% | +15.9% | +33.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -96.4% | +44.2% | -43.8% | +22.3% |
Valuation Metrics
LAZ leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 21.4x trailing earnings, LAZ trades at a 54% valuation discount to VACHU's 46.7x P/E. Adjusting for growth (PEG ratio), HLI offers better value at 1.52x vs EVR's 2.13x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $551M | $13.4B | $4.4B | $9.7B |
| Enterprise ValueMkt cap + debt − cash | $551M | $13.1B | $5.4B | $9.2B |
| Trailing P/EPrice ÷ TTM EPS | 46.67x | 24.14x | 21.36x | 23.93x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.65x | 16.61x | 18.08x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.13x | — | 1.52x |
| EV / EBITDAEnterprise value multiple | — | 16.31x | 12.07x | 16.92x |
| Price / SalesMarket cap ÷ Revenue | — | 3.46x | 1.37x | 4.07x |
| Price / BookPrice ÷ Book value/share | 1.66x | 6.49x | 4.98x | 4.40x |
| Price / FCFMarket cap ÷ FCF | — | 11.36x | 8.62x | 12.01x |
Profitability & Efficiency
Evenly matched — EVR and HLI each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
EVR delivers a 29.3% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $6 for VACHU. HLI carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to LAZ's 2.61x. On the Piotroski fundamental quality scale (0–9), HLI scores 7/9 vs VACHU's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +29.3% | +26.7% | +20.1% |
| ROA (TTM)Return on assets | +2.5% | +14.1% | +5.2% | +11.9% |
| ROICReturn on invested capital | -0.5% | +18.8% | +9.5% | +15.5% |
| ROCEReturn on capital employed | -0.7% | +17.6% | +9.5% | +20.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | — | 0.50x | 2.61x | 0.20x |
| Net DebtTotal debt minus cash | -$182,103 | -$311M | $1.1B | -$533M |
| Cash & Equiv.Liquid assets | $182,103 | $1.5B | $1.5B | $971M |
| Total DebtShort + long-term debt | $0 | $1.2B | $2.6B | $438M |
| Interest CoverageEBIT ÷ Interest expense | — | 32.72x | 4.74x | — |
Total Returns (Dividends Reinvested)
EVR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EVR five years ago would be worth $24,984 today (with dividends reinvested), compared to $11,920 for LAZ. Over the past 12 months, VACHU leads with a +61.7% total return vs HLI's -19.0%. The 3-year compound annual growth rate (CAGR) favors EVR at 46.1% vs HLI's 17.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +57.2% | -2.9% | -4.8% | -20.3% |
| 1-Year ReturnPast 12 months | +61.7% | +43.7% | +11.2% | -19.0% |
| 3-Year ReturnCumulative with dividends | +68.0% | +211.6% | +74.1% | +63.0% |
| 5-Year ReturnCumulative with dividends | +68.0% | +149.8% | +19.2% | +98.2% |
| 10-Year ReturnCumulative with dividends | +68.0% | +598.4% | +95.2% | +538.1% |
| CAGR (3Y)Annualised 3-year return | +18.9% | +46.1% | +20.3% | +17.7% |
Risk & Volatility
Evenly matched — VACHU and EVR each lead in 1 of 2 comparable metrics.
Risk & Volatility
VACHU is the less volatile stock with a -1.88 beta — it tends to amplify market swings less than EVR's 1.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EVR currently trades 87.3% from its 52-week high vs HLI's 65.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -1.88x | 1.81x | 1.73x | 0.85x |
| 52-Week HighHighest price in past year | $20.10 | $388.71 | $58.75 | $211.78 |
| 52-Week LowLowest price in past year | $10.30 | $232.29 | $38.67 | $134.41 |
| % of 52W HighCurrent price vs 52-week peak | +83.6% | +87.3% | +78.9% | +65.8% |
| RSI (14)Momentum oscillator 0–100 | 51.4 | 55.9 | 54.8 | 37.3 |
| Avg Volume (50D)Average daily shares traded | 1K | 475K | 1.2M | 593K |
Analyst Outlook
Evenly matched — EVR and LAZ each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EVR as "Buy", LAZ as "Buy", HLI as "Buy". Consensus price targets imply 35.0% upside for HLI (target: $188) vs 4.6% for LAZ (target: $49). For income investors, LAZ offers the higher dividend yield at 3.78% vs EVR's 0.96%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $382.67 | $48.50 | $188.00 |
| # AnalystsCovering analysts | — | 21 | 29 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +1.0% | +3.8% | +1.7% |
| Dividend StreakConsecutive years of raises | — | 19 | 0 | 11 |
| Dividend / ShareAnnual DPS | — | $3.25 | $1.75 | $2.41 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.9% | +2.1% | +0.5% |
HLI leads in 1 of 6 categories (Income & Cash Flow). LAZ leads in 1 (Valuation Metrics). 3 tied.
VACHU vs EVR vs LAZ vs HLI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VACHU or EVR or LAZ or HLI a better buy right now?
For growth investors, Evercore Inc.
(EVR) is the stronger pick with 29. 5% revenue growth year-over-year, versus 3. 2% for Lazard Ltd (LAZ). Lazard Ltd (LAZ) offers the better valuation at 21. 4x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Evercore Inc. (EVR) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VACHU or EVR or LAZ or HLI?
On trailing P/E, Lazard Ltd (LAZ) is the cheapest at 21.
4x versus Voyager Acquisition Corp Unit at 46. 7x. On forward P/E, Lazard Ltd is actually cheaper at 16. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Houlihan Lokey, Inc. wins at 1. 15x versus Evercore Inc. 's 1. 56x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — VACHU or EVR or LAZ or HLI?
Over the past 5 years, Evercore Inc.
(EVR) delivered a total return of +149. 8%, compared to +19. 2% for Lazard Ltd (LAZ). Over 10 years, the gap is even starker: EVR returned +598. 4% versus VACHU's +68. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VACHU or EVR or LAZ or HLI?
By beta (market sensitivity over 5 years), Voyager Acquisition Corp Unit (VACHU) is the lower-risk stock at -1.
88β versus Evercore Inc. 's 1. 81β — meaning EVR is approximately -196% more volatile than VACHU relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 3% for Lazard Ltd — giving it more financial flexibility in a downturn.
05Which is growing faster — VACHU or EVR or LAZ or HLI?
By revenue growth (latest reported year), Evercore Inc.
(EVR) is pulling ahead at 29. 5% versus 3. 2% for Lazard Ltd (LAZ). On earnings-per-share growth, the picture is similar: Evercore Inc. grew EPS 54. 7% year-over-year, compared to -19. 0% for Lazard Ltd. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VACHU or EVR or LAZ or HLI?
Houlihan Lokey, Inc.
(HLI) is the more profitable company, earning 16. 7% net margin versus 0. 0% for Voyager Acquisition Corp Unit — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLI leads at 21. 0% versus 0. 0% for VACHU. At the gross margin level — before operating expenses — EVR leads at 99. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VACHU or EVR or LAZ or HLI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Houlihan Lokey, Inc. (HLI) is the more undervalued stock at a PEG of 1. 15x versus Evercore Inc. 's 1. 56x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Lazard Ltd (LAZ) trades at 16. 6x forward P/E versus 18. 1x for Houlihan Lokey, Inc. — 1. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLI: 35. 0% to $188. 00.
08Which pays a better dividend — VACHU or EVR or LAZ or HLI?
In this comparison, LAZ (3.
8% yield), HLI (1. 7% yield), EVR (1. 0% yield) pay a dividend. VACHU does not pay a meaningful dividend and should not be held primarily for income.
09Is VACHU or EVR or LAZ or HLI better for a retirement portfolio?
For long-horizon retirement investors, Voyager Acquisition Corp Unit (VACHU) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1.
88)). Lazard Ltd (LAZ) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VACHU: +68. 0%, LAZ: +95. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VACHU and EVR and LAZ and HLI?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VACHU is a small-cap quality compounder stock; EVR is a mid-cap high-growth stock; LAZ is a small-cap income-oriented stock; HLI is a small-cap high-growth stock. EVR, LAZ, HLI pay a dividend while VACHU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.